Introduction
Preterm birth affects about one in ten pregnancies worldwide and is a leading cause of death in children under the age of five years [1] . Long-term survival has improved steadily in high-income countries and the focus of contemporary neonatal care has shifted from reducing mortality to improving long-term outcomes and optimising nutrition. Mother's own milk (MOM) confers a wide range of benefits, including improved neuro-cognitive and motor outcomes, and a reduction in sepsis. However, when MOM is unavailable, the European Society of Pediatric Gastroenterology and Nutrition, American Academy of Pediatrics and World Health Organization support the use of pasteurised human donor milk (pHDM) for preterm infants [2-4] although robust evidence of short and long-term benefits, particularly when used as a supplement to MOM, is lacking [5] [6] [7] [8] . Earlier studies surveying UK clinicians' practices suggest wide variation in use of pHDM [9, 10] . We analysed population patient-level daily data, recorded as part of a wider study [11] , to describe how pHDM is used across neonatal networks in England, and investigate whether presence of a pHDM bank is an influencing factor. 
Methods

Data source
Study population and variables
We extracted data from the NNRD on infants born below 32 weeks gestational age (GA) admitted to all 163 neonatal units in England over the complete two-year period 2012-2013. We excluded infants cared for in non-English units, without feeding data in the first two postnatal days, all infants from one tertiary NNU due to technical problems with data transfer, and those that received care in more than one network. We extracted the following variables from the NNRD: gestational age (GA) at birth, birth-weight (BW), booking network, neonatal unit on the first day of life, daily feeding data (formula, MOM, pHDM) from day of birth until day of discharge or death. Where daily feeding records were missing, we made the assumption that the infant was not given that milk.
Statistical analysis
Analyses were restricted to the first 30 postnatal days. We assessed the proportion (95% CI) of infants fed enterally and the type of feed exposure (pHDM, MOM, formula) within the first 2 postnatal days. For each network, we determined the postnatal day (median, IQR) of the first enteral feed and, where used, the first exposure to pHDM. We used two measures to evaluate pHDM use during the first 30 postnatal days by GA and network i) the proportion (95% CI) of infants fed any pHDM and ii) the proportion of care-days on which pHDM was used, classified as low (< 25%), moderate (25-50%) and high (> 50%) intensities. We fitted a logistic regression model for the outcome 'exposure to pHDM', defined as receiving pHDM on at least one of the first 30 postnatal days. We included variables considered relevant (GA, BW z score, presence of a pHDM bank in the network, and an indicator variable for each network). We assessed network variation by relating the spread of the estimates associated with the networks to the associated standard errors. As references, we arbitrarily selected one network with, and one without a pHDM bank. The significance of the parameter that represented the networks was assessed by the chi-squared test. Analyses were performed using R software [12] ; p-values < 0.05 were considered as statistically significant.
Results
Study population
In 2012 and 2013, 14,678 infants < 32 weeks GA were admitted to
